Request more info

Verily Sightline logo

A woman checking her blood pressure with a connected cuff device as part of her virtual, chronic care program — Verily Lightpath.

Partnering with scientists, communities and governments, Verily expands views of public health to better inform local and national responses through innovative solutions that monitor pathogen targets and empower decision-makers to mitigate disease at the population level.

Empowering communities to detect and empower decision-makers to mitigate disease at scale

Explore what we measure

Verily is a leader in the laboratory science behind wastewater monitoring. In collaboration with academic researchers, government agencies, and commercial organizations, our scientists conduct research to develop and validate assays needed to consistently and accurately measure the concentration of viral, fungal, and bacterial DNA and RNA in wastewater in near real time — providing information about levels of disease spread within communities.

Verily is working closely with public health specialists, clinicians, and researchers to use the data from wastewater to explore various use cases ranging from improving existing public health surveillance systems to optimizing research and development efforts.

Leading wastewater monitoring science to combat spread of infectious disease

A four-card grid displaying data graphics and captions detailing population health tracking capabilities, including activity levels, variant intelligence, forecasts, and multimodal modeling.

Talk to our team

Sightline Data Insights turns wastewater signals into localized, predictive population health intelligence to support public health and clinical decision-making.

Turning today’s signals into a healthy tomorrow

Hear from public health officials about real-time wastewater monitoring to help protect the Las Vegas community, in Verily’s short documentary series N of 1.

Watch episode (3:43)

Verily provides quality, fast turnaround wastewater monitoring results for a broad array of pathogens to hundreds of sites across the United States using our high-throughput, state-of-the-art lab leveraging automation to optimize efficiency.

Close-up view of laboratory equipment featuring graduated plastic tubes and test tube trays on a graphic-framed black background.

Two scientists in lab coats working with equipment, alongside a smartphone overlay showing health alert cards for SARS-CoV-2, Norovirus, and Influenza B.

Collage showing a blonde scientist in a lab coat and safety glasses working at a laboratory bench, using a laptop, and adjacent to lab equipment.

increased

Explore

We partnered with public health organizations during the world soccer games to track pathogens and communicate any potential health risks associated with the world soccer games. The games are over, but you can learn more about our public dashboard and post event insights.

A video snippet of webpage interface for Verily Health showing wastewater monitoring results for San Jose, CA, with status cards for SARS-CoV-2, Measles, and RSV.

View public health dashboards

As leaders in lab science, Verily operates a real-time platform for population health security. We monitor pathogens in wastewater, producing data that helps local public health teams respond faster to potential outbreaks before they surge.

See all

default

1. Wolfe, M.K., Pailos, A.H., Zulli, A., Duong, D., Shelden, B., White, B.J., and Boehm, A.B. December 2023. Wastewater Detection of Emerging Arbovirus Infections: Case Study of Dengue in the United States. Environmental Science and Technology Letters, 11(1), pp. 9-15. DOI: 10.1021/acs.estlett.3c00769., 2. Boehm, A. B., Wadford, D. A., Hughes, B., Duong, D., Chen, A., Padilla, T., Wright,C., Moua, L., Bullick, T., Salas, M., Morales, C., White, B.J., Glaser, C.A., Vugia, D.J., Yu, A.T., and Wolfe, M.K. November 2023. Trends of enterovirus D68 concentrations in wastewater in two California communities parallel trends of statewide confirmed cases, February 2021-April 2023. Emerging Infectious Disease, 29(11). DOI: 10.3201/eid2911.231080., 3. Shaw, A.G., Troman, C., Akello, J.O., O’Reilly, K.M., Gauld, J., Grow, S., Grassly, N., Steele, D., Blazes, D., Kumar, S. and the Environmental Surveillance Working Group*. Aug. 2023. Defining a research agenda for environmental wastewater surveillance of pathogens. Nat Med. 29. DOI: 10.1038/s41591-023-02457-7. *White, B.J. and Yaffe, B. part of Environmental Surveillance Working Group, 4. Boehm, A. B., Wolfe, M. K., White, B. J., Hughes, B., Duong, D., Banaei, N., and Bidwell, A. Aug. 2023. “Human norovirus (HuNoV) GII RNA in wastewater solids at 145 United States wastewater treatment plants: comparison to positivity rates of clinical specimens and modeled estimates of HuNoV GII shedders”. J. Expo. Sci. Environ. Epidemiol., pp. 1– 8. DOI: 10.1038/s41370-023-00592-4., 5. Boehm, A. B., Wolfe, M. K., White, B. J., Hughes, B., Duong, D., & Bidwell, A. July 2023. More than a Tripledemic: Influenza A Virus, Respiratory Syncytial Virus, SARS-CoV-2, and Human Metapneumovirus in Wastewater during Winter 2022–2023. Environmental Science & Technology Letters, 10(8), 622-627. DOI: 10.1021/acs.estlett.3c00385., 6. Kadonsky, K.F., Naughton, C.C., Susa, M., Olson, R., Singh, G.L., Daza-Torres, M.L., Montesinos-López, J.C., Garcia, Y.E., Gafurova, M., Gushgari, A., Cosgrove, J., White, B.J., Boehm, A.B., Wolfe, M.K., Nuño, M., Bishchel, H.N. June. 2023. Expansion of wastewater-based disease surveillance to improve health equity in California’s Central Valley: sequential shifts in case-to-wastewater and hospitalization-to-wastewater ratios. Frontiers in Pub. Health, 11. DOI: 10.3389/fpubh.2023.1141097., 7. Boehm, A. B., Wolfe, M. K., White, B. J., Hughes, B., and Duong, D. June 2023. “Divergence of wastewater SARS-CoV-2 and reported laboratory-confirmed COVID-19 incident case data coincident with wide-spread availability of at-home COVID-19 antigen tests”. PeerJ 11, e15631. DOI: 10.7717/peerj.15631., 8. Boehm, A. B., Wolfe, M. K., Wigginton, K. R., Bidwell, A., White, B. J., Hughes, B., Duong, D., Chan-Herur, V., Bischel, H. N., and Naughton, C. C. June 2023. “Human viral nucleic acids concentrations in wastewater solids from Central and Coastal California USA”. Sci Data 10.1, p. 396. DOI: 10.1038/s41597-023-02297-7., 9. Boehm, A. B., Hughes, B., Duong, D., Chan-Herur, V., Buchman, A., Wolfe, M. K., and White, B. J. Mar. 2023. “Wastewater concentrations of human influenza, metapneumovirus, parainfluenza, respiratory syncytial virus, rhinovirus, and seasonal coronavirus nucleic-acids during the COVID-19 pandemic: a surveillance study”. Lancet Microbe 4.5, e340– e348. DOI: 10.1016/S2666-5247(22)00386-X., 10. Wolfe, M. K., Yu, A. T., Duong, D., Rane, M. S., Hughes, B., Chan-Herur, V., Donnelly, M., Chai, S., White, B. J., Vugia, D. J., and Boehm, A. B. Jan. 2023. “Use of Wastewater for Mpox Outbreak Surveillance in California”. N. Engl. J. Med. 388.6, pp. 570–572. DOI: 10.1056/NEJMc2213882., 11. Kim, S., Wolfe, M. K., Criddle, C. S., Duong, D. H., Chan-Herur, V., White, B. J., and Boehm, A. B. Nov. 2022. “Effect of SARS-CoV-2 digital droplet RT-PCR assay sensitivity on COVID-19 wastewater based epidemiology”. PLOS Water 1.11, e0000066. DOI: 10.1371/journal. pwat.0000066., 12. Roldan-Hernandez, L., Graham, K. E., Duong, D., and Boehm, A. B. Nov. 2022. “Persistence of Endogenous SARS-CoV-2 and Pepper Mild Mottle Virus RNA in Wastewater-Settled Solids”. ACS ES T Water 2.11, pp. 1944–1952. DOI: 10.1021/acsestwater.2c00003., 13. Wolfe, M. K., Duong, D., Bakker, K. M., Ammerman, M., Mortenson, L., Hughes, B., Arts, P., Lauring, A. S., Fitzsimmons, W. J., Bendall, E., Hwang, C. E., Martin, E. T., White, B. J., Boehm, A. B., and Wigginton, K. R. Aug. 2022. “Wastewater-Based Detection of Two Influenza Outbreaks”. Environ. Sci. Technol. Lett. 9.8, pp. 687–692. DOI: 10.1021/acs. Estlett.2c00350., 14. Boehm, A. B., Hughes, B., Wolfe, M. K., White, B. J., Duong, D., and Chan-Herur, V. June 2022. “Regional Replacement of SARS-CoV-2 Variant Omicron BA.1 with BA.2 as Observed through Wastewater Surveillance”. Environ Sci Technol Lett 9.6, pp. 575–580. DOI: 10.1021/acs.estlett.2c00266., 15. Huisman, J. S., Scire, J., Caduff, L., Fernandez-Cassi, X., Ganesanandamoorthy, P., Kull, A., Scheidegger, A., Stachler, E., Boehm, A. B., Hughes, B., Knudson, A., Topol, A., Wigginton, K. R., Wolfe, M. K., Kohn, T., Ort, C., Stadler, T., and Julian, T. R. May 2022. “Wastewater-based estimation of the effective reproductive number of SARS-CoV-2”. Env- iron. Health Perspect. 130.5, p. 57011. DOI: 10.1289/EHP10050., 16. Schoen, M. E., Wolfe, M. K., Li, L., Duong, D., White, B. J., Hughes, B., and Boehm, A. B. May 2022. “SARS-CoV-2 RNA Wastewater Settled Solids Surveillance Frequency and Impact on Predicted COVID-19 Incidence Using a Distributed Lag Model”. ACS ES T Water 2.11, pp. 2167–2174. DOI: 10.1021/acsestwater.2c00074., 17. Wolfe, M., Hughes, B., Duong, D., Chan-Herur, V., Wigginton, K. R., White, B. J., and Boehm, A. B. Apr. 2022. “Detection of SARS-CoV-2 Variants Mu, Beta, Gamma, Lambda, Delta, Alpha, and Omicron in Wastewater Settled Solids Using Mutation-Specific Assays Is As- sociated with Regional Detection of Variants in Clinical Samples”. Appl. Environ. Microbiol. 88.8, e0004522. DOI: 10.1128/aem.00045-22., 18. Yu, A. T., Hughes, B., Wolfe, M. K., Leon, T., Duong, D., Rabe, A., Kennedy, L. C., Ravuri, S., White, B. J., Wigginton, K. R., Boehm, A. B., and Vugia, D. J. Mar. 2022. “Estimat- ing Relative Abundance of 2 SARS-CoV-2 Variants through Wastewater Surveillance at 2 Large Metropolitan Sites, United States”. Emerg. Infect. Dis. 28.5, pp. 940–947. DOI: 10.3201/eid2805.212488., 19. Hughes, B., Duong, D., White, B. J., Wigginton, K. R., Chan, E. M. G., Wolfe, M. K., and Boehm, A. B. Feb. 2022. “Respiratory Syncytial Virus (RSV) RNA in Wastewater Settled Solids Reflects RSV Clinical Positivity Rates”. Environ. Sci. Technol. Lett. 9.2, pp. 173–178. DOI: 10.1021/acs.estlett.1c00963., 20. Kim, S., Kennedy, L. C., Wolfe, M. K., Criddle, C. S., Duong, D. H., Topol, A., White, B. J., Kantor, R. S., Nelson, K. L., Steele, J. A., Langlois, K., Griffith, J. F., Zimmer-Faust, A. G., McLellan, S. L., Schussman, M. K., Ammerman, M., Wigginton, K. R., Bakker, K. M., and Boehm, A. B. Feb. 2022. “SARS-CoV-2 RNA is enriched by orders of magnitude in primary settled solids relative to liquid wastewater at publicly owned treatment works”. Environ. Sci. 8.4, pp. 757–770. DOI: 10.1039/d1ew00826a., 21. Kirby, A. E., [...], White, B. J., et al. Jan. 2022. “Notes from the Field: Early Evidence of the SARS-CoV-2 B.1.1.529 (Omicron) Variant in Community Wastewater - United States, November-December 2021”. MMWR Morb. Mortal. Wkly. Rep. 71.3, pp. 103–105. DOI: 10.15585/mmwr.mm7103a5., 22. Wolfe, M. K., Topol, A., Knudson, A., Simpson, A., White, B.J., Vugia, D. J., Yu, A. T., Li, L., Balliet, M., Stoddard, P., Han, G. S., Wigginton, K. R., and Boehm, A. B. Sept. 2021. “High- Frequency, High-Throughput Quantification of SARS-CoV-2 RNA in Wastewater Settled Solids at Eight Publicly Owned Treatment Works in Northern California Shows Strong As- sociation with COVID-19 Incidence”. mSystems 6.5, e0082921. DOI: 10.1128/mSystems. 00829-21., 23. Simpson, A., Topol, A., White, B. J., Wolfe, M. K., Wigginton, K. R., and Boehm, A. B. Aug. 2021. “Effect of storage conditions on SARS-CoV-2 RNA quantification in wastewater solids”. PeerJ 9, e11933. DOI: 10.7717/peerj.11933. 24. Boehm, A. B., Shelden, B., Duong, D., Banaei, N., White B. J., Wolfe, M. K. “A retrospective longitudinal study of adenovirus group F, norovirus GI and GII, rotavirus, and enterovirus nucleic acids in wastewater solids at two wastewater treatment plants: solid-liquid partitioning and relation to clinical testing data”. mSphere 0:e00736-23. DOI: 10.1128/msphere.00736-23. 25. Zulli, A., Chan, E. M. G., Shelden, B., Duong, D., Xu, X. S., White, B. J., Wolfe, M. K., Boehm, A. B. “Prospective study of Candida auris nucleic acids in wastewater solids in 190 wastewater treatment plants in the United States suggests widespread occurrence”. mBio 0:e00908-24. DOI: 10.1128/mbio.00908-24. 26. Boehm, A. B., Wolfe, M. K. , Bidwell, A. L., Zulli, A., Chan-Herur. V., White, B. J., Shelden, B., Duong, D. “Human pathogen nucleic acids in wastewater solids from 191 wastewater treatment plants in the United States”. Sci Data. 2024 Oct 17;11(1):1141. DOI: 10.1038/s41597-024-03969-8. PMID: 39420189; PMCID: PMC11487133.

Wastewater-based pathogen testing and data insights to combat infectious disease

Verily Sightline | Public health solutions | Precision Health Company

Verily Logo

The AI-native platform for precision health

A close-up cropped inside a geometric graphic layout showing a healthcare professional gently holding an elderly person's hands in a comforting gesture

Expanding views of public health

Verily Sightline

Empowering communities to detect and empower decision-makers to mitigate disease at scale

Sightline wastewater testing

Leading wastewater monitoring science to combat spread of infectious disease

What it delivers

Sightline data insights

Turning today’s signals into a healthy tomorrow

A watershed moment in public health

Hear from public health officials about real-time wastewater monitoring to help protect the Las Vegas community, in Verily’s short documentary series N of 1.

What we measure

The Sightline difference